Vitamin B trial offers hope to cut dementia
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists are hoping to start a nationwide clinical trial next year involving 1,000 elderly people across Britain to see whether taking vitamin B supplements can reduce the chances of developing senile dementia.
Research published last year on 270 men and women with mild cognitive impairment showed that a pill containing high doses of B6, B12 and folic acid can significantly reduce the chances of brain shrinkage over two years.
Scientists hope that using dietary supplements to improve mild cognitive impairment, which is associated with the onset of Alzheimer's disease, might delay the onset of dementia.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments